Current Problems in Pediatric and Adolescent Health Care
Volume 37, Issue 3 , Pages 86-105 , March 2007

Celiac Disease Among Children and Adolescents

References 

  1. Adams F. In: The extant works of Aretaeus the Cappadocian. London: London Sydenham Society; 1856;p. 350
  2. Gee SJ. On the coeliac affection. St. Bartholomew’s Hospital Report. 1888;24:17–20
  3. Haas SV. The value of the banana in the treatment of coeliac disease. Am J Dis Child. 1924;24:421–437
  4. van Bergen-Henegouwen GP, Mulder CJ, Dicke WK. Pioneer in the gluten free diet: Willem-Karel Dicke 1905-1962, over 50 years of gluten free diet. Gut. 1993;34:1473–1475
  5. Van de Kamer JH, Weijers HA, Dicke WK. Coeliac disease IV (An investigation into the injurious constituents of wheat in connection with coeliac disease). Acta Paediatr. 1953;42:223–231
  6. Dicke WK. Simple dietary treatment for the syndrome of Gee-Herter. Ned Tijdschr Geneeskd. 1941;85:1715–1716(in Dutch)
  7. Dicke WK. Coeliac disease: investigation of the harmful effects of certain types of cereal on patients with celiac disease. Netherlands: University of Utrecht; 1950;(Thesis) (in Dutch)
  8. Shiner M. Duodenal biopsy. Lancet. 1956;i:17–19
  9. Masjedizadeh R, Hajiani E, Hashemi J, Shayesteh AA, Moula K, Rajabi T. Celiac disease in South-West of Iran. World J Gastroenterol. 2006;12:4416–4419
  10. Malekzade H, Sachdev A, Fahid AS. Coeliac disease in developing countries: Middle East, India and North Africa. Best Pract Res Clin Gastroenterol. 2005;19:351–358
  11. Green PHR, Jabri B. Coeliac disease. Lancet. 2003;362:383–391
  12. Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH. Prevalence of coeliac disease in Northern Ireland. Lancet. 1997;350:1370
  13. Kolho KL, Farkkila MA, Savilahti E. Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol. 1998;33:1280–1283
  14. Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet. 1994;343:200–203
  15. Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in the Netherlands. Lancet. 1999;353:813
  16. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med. 2003;348:2517–2524
  17. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286–292
  18. Gandolfi L, Pratesi R, Cordoba JCM, Tauil PL, Gasparin M, Catassi C. Prevalence of celiac disease among blood donors in Brazil. Am J Gastroenterol. 2000;95:689–692
  19. Gomez JC, Selvaggio GS, Viola M, Pizarro B, la Motta G, de Barrio S, et al. Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area. Am J Gastroenterol. 2001;96:2700–2704
  20. Steens RFR, Csizmadia CGDS, George EK, Ninaber MK, Hira Sing RA, Mearin ML. Better recognition of childhood celiac disease in the Netherlands and its changing clinical picture: a national prospective study 1993-2000. J Pediatr. 2005;147:239–242
  21. Mearin ML, Koninckx CR, Biemond I, Polanco I, Pena AS. Influence of genetic factors on the serum levels of antigliadin antibodies in celiac disease. J Pediatr Gastroenterol Nutr. 1984;3:373–377
  22. Congia M, Cucca F, Frau F, Lampis R, Melis L, Clemente MG, et al. A gene dosage effect of the QA80501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol. 1994;40:138–142
  23. Ploski R, Ek J, Thorsby E, Sollid M. On the HLA-DQ (α1*0501, β1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens. 1993;41:173–177
  24. Greco L, Percopo S, Clot F, Bouguerra F, Babron MC, Eliaou JF, et al. Lack of correlation between genotype and phenotype in celiac disease. J Pediatr Gastroenterol Nutr. 1998;26:286–290
  25. Dickey W, McMillan SA. Increasing numbers at a specialist coeliac clinic: contribution of serological testing in primary care. Dig Liver Dis. 2005;37:928–933
  26. Sood A, Midha V, Sood N, Avasthi G, Sehgal A. Prevalence of celiac disease among school children in Punjab, North India. J Gastroenterol Hepatol. 2006;21:1622–1625
  27. Ansaldi N, Palmas T, Corrias A, Barbato M, D’Altiglia MR, Campanozzi A, et al. Autoimmune thyroid disease and celiac disease in children. J Pediatr Gastroenterol Nutr. 2003;37:63–66
  28. Greco L, De Seta L, D’Adamo G, Baldassarre C, Mayer M, Siani P, et al. Atopy and coeliac disease: bias or true relation?. Acta Paediatr Scand. 1990;79:670–674
  29. Kero J, Gissler M, Hemminki E, Isolauri E. Could TH1 and TH2 diseases coexist? (Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study). J Allergy Clin Immunol. 2001;108:781–783
  30. Ertekin V, Selimoglu MA, Gursan N, Ozkan B. Idiopathic pulmonary hemosiderosis in children with celiac disease. Respir Med. 2006;100:568–569
  31. Hervonen K, Hakanen M, Kaukinen K, Collin P, Reunala T. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol. 2002;37:51–55
  32. Lemberg D, Day AS, Bohane T. Coeliac disease presenting as dermatitis herpetiformis in infancy. J Paediatr Child Health. 2005;41:294–296
  33. Csizmadia CGDS, Mearin ML, Oren A, Kromhout A, Crusius JB, von Blomberg BM, et al. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Paediatr. 2000;137:756–761
  34. Ivarsson SA, Carlsson A, Bredberg A, Alm J, Aronsson S, Gustafsson J, et al. Prevalence of coeliac disease in Turner syndrome. Acta Paediatr. 1999;88:933–936
  35. George EK, Mearin ML, Bouquet J, von Blomberg BM, Stapel SO, van Elburg RM, et al. High frequency of celiac disease in Down syndrome. J Paediatr. 1996;128:555–557
  36. Voss LD, Mulligan J, Betts PR, Wilkin TJ. Poor growth in school entrants as an index of organic disease: the Wessex growth study. BMJ. 1992;305:1400–1402
  37. Ahmed ML, Allen AD, Sharma A, Macfarlane JA, Dunger DB. Evaluation of a district growth screening programme: the Oxford Growth Study. Arch Dis Child. 1993;69:361–365
  38. Van Rijn JCW, Grote FK, Oostdijk W, Wit JM. Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms. Arch Dis Child. 2004;89:882–883
  39. Mustalahti K, Sulkanen S, Holopainen P, Laurila K, Collin P, Partanen J, et al. Coeliac disease among healthy members of multiple case coeliac disease families. Scand J Gastroenterol. 2002;37:161–165
  40. Mearin ML, Ivarsson A, Dickey W. Coeliac disease: is it time for mass screening?. Best Pract Res Clin Gastroenterol. 2005;19:441–452
  41. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in celiac patients. Gastroenterology. 1999;117:303–310
  42. Gough KR, Reade AE, Nash JM. Intestinal reticulosis as a complication of idiopathic steatorrhoea. Gut. 1962;3:232–239
  43. Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease—effect of a gluten free diet. Gut. 1989;30:333–338
  44. Cooper BT, Holmes GKT, Cooke WT. Lymphoma risk in coeliac disease of later life. Digestion. 1982;23:89–92
  45. Swinson CM, Slavin G, Coles EC, Booth CC. Coeliac disease and malignancy. Lancet. 1983;1:111–115
  46. Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA. 2002;287:1413–1419
  47. Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis in Sweden. Gastroenterology. 2002;123:1428–1435
  48. Mearin ML, Catassi C, Brousse N, Brand R, Collin P, Fabiani E, et al. European multicenter study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepat. 2006;18:187–194
  49. Johnston SD, Watson RG. Small bowel lymphoma in unrecognized coeliac disease: cause for concern?. Eur J Gastroenterol Hepatol. 2000;12:645–648
  50. Schweizer JJ, Oren A, Mearin ML Working Group on Celiac Disease and Malignancy of the European Society for Paediatric Gastroenterology Hepatology and Nutricion. Cancer in children with celiac disease: a survey of the European Society for Paediatric Gastroenterology Hepatology and Nutricion. J Pediatr Gastroenterol Nutr. 2001;33:97–99
  51. Wood AJJ. Treatment of postmenopausal osteoporosis. N Engl J Med. 1998;336:736–746
  52. Meyer D, Stavropolous S, Diamond B, Shane E, Green PH. Osteoporosis in a North American adult population with CD. Am J Gastroenterol. 2001;96:112–119
  53. Hartman C, Hino B, Lerner A, Eshach-Adiv O, Berkowitz D, Shaoul R, et al. Bone quantitative ultrasound and bone mineral density in children with celiac disease. J Pediatr Gastroenterol Nutr. 2004;39:504–510
  54. Corazza GR, Di Stefano M, Mauriño E, Bai JC. Bones in coeliac disease: diagnosis and treatment. Best Pract Res Clin Gastroenterol. 2005;19:453–465
  55. West J, Logan RF, Card TR, Smith C, Hubbard R. Fracture risk in people with CD: a population-based cohort study. Gastroenterology. 2003;125:429–436
  56. Valdimarsson T, Lofman O, Toss G, Strom M. Reversal of osteopenia with diet in adult coeliac disease. Gut. 1996;38:322–327
  57. Babron MC, Nilsson S, Adamovic S, Naluai AT, Wahlstrom J, Ascher H, et al. European Genetics Cluster on Coeliac Disease Meta and pooled analysis of European coeliac disease data. Eur J Hum Genet. 2003;11:828–834
  58. Mora S, Weber G, Barera G, Proverbio MC, Weber G, Bianchi C, et al. Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr. 1993;57:224–230
  59. van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:323–339
  60. Nistico L, Fagnani C, Coto I, Percopo S, Cotichini R, Limongelli MG, et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut. 2006;55:803–808
  61. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med. 1989;169:345–350
  62. Mearin ML, Biemond I, Pena A, Polanco I, Vazquez C, Schreuder GT, et al. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut. 1983;24:532–537
  63. Mearin ML, Bouquet J, Mourad N, Schoorel E, Sinaasappel M, Biemond I, et al. HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Clin Genet. 1985;27:45–50
  64. van Belzen MJ, Mulder CJJ, Zhernakova A, Pearson PL, Houwen RHJ, Wijmenga C. CTLA4+49 A/G and CT60 polymorphisms in Dutch coeliac disease patients. Eur J Hum Genet. 2004;12:782–785
  65. Monsuur AJ, de Bakker PIW, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet. 2005;37:1341–1344
  66. Shewry PR, Tatham AS. The prolamin storage proteins of cereal seeds: structure and evolution. Biochem J. 1990;267:1–12
  67. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F. Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501,β1*0201) molecule. Immunogenetics. 1996;44:246–253
  68. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM. Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol. 1996;8:177–182
  69. Molberg Ø, McAdam S, Körner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut derived T cells in celiac disease. Nat Med. 1998;4:713–717
  70. van de Wal Y, Kooy YMC, van Veelen P, Pena S, Mearin L, Papadopoulos G, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol. 1998;161:1585–1588
  71. Arentz-Hansen H, McAdam SN, Molberg Ø, Fleckenstein B, Lundin KE, Jorgensen TJ, et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology. 2002;123:803–809
  72. Vader W, Kooy Y, van Veelen P, de Ru A, Harris D, Benckhuijsen W, et al. The gluten response in children with recent onset celiac disease (A highly diverse response towards multiple gliadin and glutenin derived peptides). Gastroenterology. 2002;122:1729–1737
  73. Arentz-Hansen H, Körner R, Molberg Ø, Quarsten H, Vader W, Kooy YM, et al. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 2000;191:603–612
  74. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med. 2000;6:337–342
  75. Vader W, Stepniak D, Bunnik EM, Mearin L, Thompson A, van Rood JJ, et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology. 2003;125:1105–1113
  76. Vader W, Stepniak D, Kooy Y, de Haan W, Drijfhout JW, Van Veelen PA, et al. The HLA-DQ2 gene dose effect in Celiac Disease is directly related to the magnitude and breadth of gluten-specific T-cell responses. Proc Natl Acad Sci USA. 2003;100:12390–12395
  77. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003;362:30–37
  78. Hüe S, Mention J-J, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. Role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004;21:367–377
  79. Koning F, Schuppan D, Cerf-Bensussan N, Sollid LM. Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol. 2005;19:373–387
  80. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004;21:357–366
  81. Mention JJ, Ben Ahmed M, Begue B, Verkarre V, Asnafi V, Colombel JF, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology. 2003;125:730–745
  82. Meeuwisse GW. Diagnostic criteria in coeliac disease. Acta Paediatr Scand. 1970;59:461–463
  83. Branski D, Faber J, Freier S, Gottschalk-Sabag S, Shiner M. Histologic evaluation of endoscopic versus suction biopsies of small intestinal mucosae in children with and without celiac disease. J Pediatr Gastroenterol Nutr. 1998;27:6–11
  84. Hogberg L, Nordwall M, Stenhammar L. One thousand small-bowel biopsies in children (A single-port versus a double-port capsule). Scand J Gastroenterol. 2001;36:1230–1232
  85. Walker-Smith JA, Guandalini S, Schmitz J, Schmerling DH, Visakorpi JK. Revised criteria for the diagnosis of coeliac disease (Report of the working group of the European Society for Paediatric Gastroenterology and Nutrition). Arch Dis Child. 1990;65:909–911
  86. Marsh MN. Gluten, major histocompatibility complex, and the small intestine (A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”)). Gastroenterology. 1992;102:330–354
  87. Marsh MN, Bjarnason I, Shaw S, Ellis A, Baker R, Peters TJ. Studies of intestinal lymphoid tissue (XIV-HLA status, mucosal morphology, permeability and epithelial lymphocyte population in first degree relatives of patients with coeliac disease). Gut. 1990;31:32–36
  88. Wahab PJ, Meijer JW, Mulder CJ. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol. 2002;118:459–463
  89. De Giacomo C, Gianatti A, Negrini R, Perotti P, Bawa P, Maggiore G, et al. Lymphocytic gastritis: a positive relationship with celiac disease. J Pediatr. 1994;124:57–62
  90. Chan KN, Phillips AD, Mirakian R, Walker-Smith JA. Endomysial antibody screening in children. J Pediatr Gastroenterol Nutr. 1994;18:316–320
  91. Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, et al. Evidence Report/Technology Assessment No. 104. Rockville, MD: Agency for Healthcare Research and Quality; 2004;(Prepared by the University of Ottawa Evidence-based Practice Center, under Contract No. 290-02-0021.) AHRQ Publication No. 04-E029-2; July
  92. Abrams J, Diamond B, Rotterdam H, Green PHR. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci. 2004;49:546–550
  93. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797–801
  94. Dieterich W, Laag E, Schöpper H, Volta U, Ferguson A, Gillett H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 1998;115:1317–1321
  95. Wong RC, Wilson RJ, Steele RH, Radford-Smith G, Adelstein S. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol. 2002;55:488–494
  96. Lock RJ, Stevens S, Pitcher MC, Unsworth DJ. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?. Eur J Gastroenterol Hepatol. 2004;16:467–470
  97. Collin P, Kaukinen K, Vogelsang H, Korponay-Szabo I, Sommer R, Schreier E, et al. Anti-endomysial and anti-human recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease (A biopsy-proven European multicentre study). Eur J Gastroenterol. 2005;17:85–91
  98. Rittmeyer C, Rhoads JM. IgA deficiency causes false-negative endomysial antibody results in celiac disease. J Pediatr Gastroenterol Nutr. 1996;23:504–506
  99. Korponay-Szabo IR, Dahlbom I, Laurila K, Koskinen S, Woolley N, Partanen J, et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut. 2003;52:1567–1571
  100. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, et al. Guidelines for the Diagnosis and Treatment of Celiac Disease in Children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1–19
  101. Wilson JM, Jungner G. Principles and Practice of Screening for Disease. Geneva: World Health Organisation; 1968;
  102. Shamir R, Hernell O, Leshno M. Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making. 2006;26:282–293
  103. Ellis HJ, Ciclitira PJ. In vivo gluten challenge in celiac disease. Can J Gastroenterol. 2001;15:243–247
  104. Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma VM, Jarvinen RM, Uusitupa MI, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med. 1995;333:1033–1037
  105. Janatuinen EK, Kemppainen TA, Julkunen RJ, Kosma VM, Maki M, Heikkinen M, et al. No harm from five year ingestion of oats in coeliac disease. Gut. 2002;50:332–335
  106. Kumar PJ, Farthking MGJ. Oats and celiac disease. N Engl J Med. 1995;333:1075–1076
  107. Hardman CM, Garioch JJ, Leonard JN, Thomas HJ, Walker MM, Lortan JE, et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med. 1997;337:1884–1887
  108. Hoffenberg EJ, Haas J, Drescher A, Barnhurst R, Osberg I, Bao F, et al. A trial of oats in children with newly diagnosed celiac disease. J Pediatr. 2000;137:361–366
  109. Picarelli A, Di Tola M, Sabbatella L, Gabrielli F, Di Cello T, Anania MC, et al. Immunologic evidence of no harmful effect of oats in celiac disease. Am J Clin Nutr. 2001;74:137–140
  110. Holm K, Maki M, Vuolteenaho N, Mustalahti K, Ashorn M, Ruuska T, et al. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther. 2006;15:1463–1472
  111. Hernando A, Mujico JR, Juanas D, Mendez E. Confirmation of the cereal type in oat products highly contaminated with gluten. J Am Diet Assoc. 2006;106:665–666
  112. Arentz-Hansen H, Fleckenstein B, Molberg Ø, Scott H, Koning F, Jung G, et al. The molecular basis for oat intolerance in patients with celiac disease. PLoS Med. 2004;1:e1;[Epub 2004 Oct 19]
  113. Spaenij-Dekking L, Kooy-Winkelaar Y, Koning F. The Ethiopian cereal tef in celiac disease. N Engl J Med. 2005;353:1748–1749
  114. Mendez E, Vela C, Immer U, Janssen FW. Report of a collaborative trial to investigate the performance of the R5 enzyme linked immunoassay to determine gliadin in gluten-free food. Eur J Gastroenterol Hepatol. 2005;17:1053–1063
  115. Lamontagne P, West GE, Galibois I. Quebecers with celiac disease: analysis of dietary problems. Can J Diet Prac Res. 2001;62:175–181
  116. Kumar PJ, Walker-Smith J, Milla P, Harris G, Colyer J, Halliday R. The teenage coeliac: follow up study of 102 patients. Arch Dis Child. 1988;63:916–920
  117. Anson O, Weizman Z, Zeevi N. Celiac disease: parental knowledge and attitudes of dietary compliance. Pediatrics. 1990;85:98–103
  118. Mayer M, Greco L, Troncone R, Auricchio S, Marsh MN. Compliance of adolescents with coeliac disease with a gluten free diet. Gut. 1991;32:881–885
  119. Ljungman G, Myrdal U. Compliance in teenagers with coeliac disease—a Swedish follow-up study. Acta Paediatr. 1993;82:235–238
  120. Fabiani E, Catassi C, Villari A, Gismondi P, Pierdomenico R, Ratsch IM, et al. Dietary compliance in screening-detected coeliac disease adolescents. Am J Clin Nutr. 1996;412(Suppl):65–67
  121. Mariani P, Viti MG, Montuori M, La Vecchia A, Cipolletta E, Calvani L, et al. The gluten-free diet: a nutritional risk for adolescents with celiac disease. J Pediatr Gastroenterol Nutr. 1998;27:519–523
  122. Hopman GD, le Cessie S, von Blomberg BME, Mearin ML. Nutritional management of the gluten-free diet in young people with celiac disease in the Netherlands. J Pediatr Gastroenterol Nutr. 2006;43:102–108
  123. Burgin-Wolff A, Dahlbom I, Hadziselimovic F, Petersson CJ. Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease. Scand J Gastroenterol. 2002;37:685–691
  124. Troncone R, Mayer M, Spagnuolo F, Maiuri L, Greco L. Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. J Pediatr Gastroenterol Nutr. 1995;21:69–72
  125. Sategna-Guidetti C, Grosso S, Bruno M, Grosso SB. Reliability of immunologic markers of celiac sprue in the assessment of mucosal recovery after gluten withdrawal. J Clin Gastroenterol. 1996;23:101–104
  126. Vahedi K, Mascart F, Mary JY, Laberenne JE, Bouhnik Y, Morin MC, et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol. 2003;98:1079–1087
  127. Kemppainen T, Uusitupa M, Janatuinen E, Jarvinen R, Julkunen R, Pikkarainen P. Intakes of nutrients and nutritional status in coeliac patients. Scand J Gastroenterol. 1995;30:575–579
  128. Hallert C, Grännö C, Hultén S, Midhagen G, Strom M, Svensson H. Living with coeliac disease. Scand J Gastroenterol. 2002;37:39–42
  129. Lewis HM, Reunala TL, Garioch JJ, Leonard JN, Fry JS, Collin P, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996;135:363–367
  130. Collin P, Vilska S, Heinonen PK, Hallstrom O, Pikkarainen P. Infertility and coeliac disease. Gut. 1996;39:382–384
  131. Nørgård B, Fonager K, Sørensen HT, Olsen J. Birth outcomes of women with celiac disease: a nationwide historical cohort study. Am J Gastroenterol. 1999;94:2435–2440
  132. Eiser C, Morse R. Can parents rate their child’s health-related quality of life? (Results of a systematic review). Qual Life Res. 2001;10:347–357
  133. Petersen C, Schmidt S, Power M, Bullinger M The DISABKIDS Group. Development and pilot-testing of a health-related quality of life chronic generic module for children and adolescents with chronic health conditions: a European perspective. Qual Life Res. 2005;14:1065–1077
  134. Gill TM, Feinstein AR. A critical appraisal of the quality of life measurements. JAMA. 1994;272:619–626
  135. Koopman HM, Theunissen NCM, Vogels TGC, Kamphuis RP, Verrips EGH. The DUX-25, a short form questionnaire for measuring health related quality of life of children with chronic illness. Qual Life Res. 1998;7:619
  136. Loonen HJ, Grootenhuis MA, Last BF, Koopman HM, Derkx HHF. Quality of life in paediatric inflammatory bowel disease measured by a generic and a disease specific questionnaire. Acta Paediatr. 2002;91:348–354
  137. Peterson C, Schmidt S, Power M, Bullinger M The DISABKIDS Group. Development and pilot-testing of a health-related quality of life chronic generic module for children and adolescents with chronic health conditions: a European perspective. Qual Life Res. 2005;14:1065–1077
  138. Kolsteren MMP, Koopman HM, Schalekamp G, Mearin ML. Health-related quality of life in children with celiac disease. J Pediatr. 2001;138:593–595
  139. Zarkadas M, Cranney A, Case S, Molloy M, Switzer C, Graham ID, et al. The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet. 2006;19:41–49
  140. Ivarsson A, Persson LÅ, Nyström L, Ascher H, Cavell B, Danielsson L, et al. Epidemic of celiac disease in Swedish children. Acta Paediatr. 2000;89:65–71
  141. Ivarsson A, Hernell O, Stenlund H, Persson LÅ. Breast-feeding protects against celiac disease. Am J Clin Nutr. 2002;75:914–921
  142. Brandtzaeg PE. Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Ann NY Acad Sci. 2002;964:13–45
  143. Strobel S. Oral tolerance, systemic immunoregulation and autoimmunity. Ann NY Acad Sci. 2002;968:47–58
  144. Falth-Magnusson Franzen L, Jansson G, Laurin P, Stemhammer L. Infant feeding history shows distinct differences between Swedish celiac and reference children. Pediatr Allergy Immunol. 1996;7:1–5
  145. Hanson LA. Breastfeeding provides passive and likely long-lasting active immunity. Ann Allergy Asthma Immunol. 1998;81:523–537
  146. Boom van den SAM, Kimber AC, Morgan JB. Weaning practices in children up to 19 months of age in Madrid. Acta Paediatr. 1995;84:854–858
  147. Ascher H, Holm K, Kristiansson B, Mäki M. Influence of infant feeding and gluten intake on coeliac disease. Arch Dis Child. 1997;76:113–117
  148. Challacombe DN, Mecrow IK, Elliott K, Clarke FJ, Wheeler EE. Changing infant feeding practices and declining incidence of celiac disease in West Somerset. Arch Dis Child. 1997;77:206–209
  149. Mitt K, Uibo O. Low cereal intake in Estonian infants: the possible explanation for the low frequency of coeliac disease in Estonia. Eur J Clin Nutr. 1998;52:85–88
  150. Norris JM, Barriga K, Hoffenberg EJ. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA. 2005;293:2343–2351
  151. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child. 2006;91:39–43
  152. Farrel RJ. Infant gluten and celiac disease: too early, too late, too much, too many questions. JAMA. 2005;293:2410–2412
  153. WHO. In: The optimal duration of exclusive breastfeeding (Systematic Review). 2001;p. 28–30March, Geneva
  154. Cattaneo A, Yngve A, Koletzko B, Guzman LR. Promotion of Breastfeeding in Europe Project (Protection, promotion and support of breast-feeding in Europe: current situation). Public Health Nutr. 2005;8:39–46
  155. Spaenij-Dekking L, Kooy-Winkelaar Y, van Veelen P, Drijfhout JW, Jonker H, van Soest L, et al. Natural variation in toxicity of wheat accessions for celiac disease patients (Potential for selection and breeding of non-toxic wheat varieties). Gastroenterology. 2005;129:797–806
  156. Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, et al. Structural basis for gluten intolerance in celiac sprue. Science. 2002;297:2275–2279

 The author has no commercial interest in the subject and no financial relationships or other relationships that would contribute to a conflict of interest.

PII: S1538-5442(07)00002-8

doi: 10.1016/j.cppeds.2007.01.001

Current Problems in Pediatric and Adolescent Health Care
Volume 37, Issue 3 , Pages 86-105 , March 2007

Article Tools

* Image Usage & Resolution